Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study

Hypertension Research

Volumn 34, Issue 8, 2011, Pages 957-962

  Teramoto, Tamio ^a   Kawamori, Ryuzo ^b   Miyazaki, Shigeru ^c   Teramukai, Satoshi ^d  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO TEISHIN HOSPITAL   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

blood pressure; diet; essential hypertension; metabolic syndrome; prospective observational study

Indexed keywords

ADULT; AGED; ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FISH; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POTASSIUM INTAKE; POTASSIUM RESTRICTION; PREVALENCE; QUESTIONNAIRE; SEX DIFFERENCE; SODIUM INTAKE; SOYBEAN; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; DIET; FEMALE; HUMANS; HYPERTENSION; JAPAN; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POTASSIUM, DIETARY; PREVALENCE; QUESTIONNAIRES; SEX FACTORS; SODIUM, DIETARY;

EID: 79961175928     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.63     Document Type: Article

References (30)

1. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24h urinary sodium and potassium excretion. BMJ 1988; 297: 319-328.
2. Law MR, Frost CD, Wald NJ. Analysis of data from trials of salt reduction. BMJ 1991; 302: 819-824.
3. Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996; 275: 1590-1597. (Pubitemid 26154246)
4. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller III ER, Simons-Morton DG, Karanja N, Lin P-H, Aickin M, Most-Windhauser MM, Moore TJ, Proschan MA, Cutler JA. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344: 3-10. (Pubitemid 32064838)
5. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) rationale for salt restriction and salt-restriction target level for the management of hypertension. Hypertens Res 2007; 30: 879-886. (Pubitemid 350123373)
6. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-1315. (Pubitemid 33016494)
7. Staessen JA, Wang JG, Thijs L. Calcium-channel blockade and cardiovascular prognosis: recent evidence from clinical outcome trials. Am J Hypertens 2002; 15: 85S-93S. (Pubitemid 34734802)
8. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21: 1055-1076. (Pubitemid 36667856)
9. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res 2005; 28: 385-407. (Pubitemid 41014801)
10. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82-96. (Pubitemid 44305278)
11. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer N, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47: 296-308. (Pubitemid 43189776)
12. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H, on behalf of The Japanese Society of Hypertension Committee. Japanese Society of Hypertension Committee: the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
13. Outline for the Results of the National Health and Nutrition Survey Japan 2008 Available at: http://www.mhlw.go.jp/houdou/2009/11/dl/h1109-1b.pdf.
14. Kawano Y, Tsuchihashi T, Matsuura H, Ando K, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (2) assessment of salt intake in the management of hypertension. Hypertens Res 2007; 30: 887-893. (Pubitemid 350120965)
15. Hoffmann IS, Cubeddu LX. Salt and the metabolic syndrome. Nutr Metab Cardiovasc Dis 2009; 19: 123-128.
16. Rodrigues SL, Baldo MP, de Sá Cunha R, Andreão RV, del Carmen Bisi Molina M, Gonçalves CP, Danttas EM, Mill JG. Salt excretion in normotensive individuals with metabolic syndrome: a population-based study. Hypertens Res 2009; 32: 906-910.
17. GISSI-Prevenzione investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-455.
18. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304. (Pubitemid 34219443)
19. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276-282.
20. Teramoto T, Fujita T, Kawamori R, Miyazaki S, Teramukai S, Igarashi M. OMEGA Study: design, baseline data, metabolic syndrome prevalence in a large-scale observational study of hypertensive patients: the Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement Study. Hypertens Res 2008; 31: 2011-2017.
21. Arakawa K, Matsushita Y, Matsuo H, Ikeda N, Iwashita M, Kuramoto K. Examination of the efficiency of salt taste preference questionnaire in hypertensive patients-results from post marketing surveillance of Olmetecs tablets and Calblocks tablets. Rinsho Iyaku 2009; 25: 723-734 (in Japanese).
22. Matsuzawa Y, Kita T, Saitoh Y, Teramoto T, Nakao K, Miyazaki S, Seino Y, Yamada N, Shimamoto K, Katayama S, Kugiyama K, Daida H, Fujita T, Makino H, Ikeda Y, Funahashi T, Nakamura T. Committee to evaluate diagnostic standards for metabolic syndrome: definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 2005; 94: 794-809 (in Japanese).
23. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301.
24. Ueshima H, Stamler J, Elliott P. Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP Study. Hypertension 2007; 50: 313-319. (Pubitemid 47205779)
25. Geleijnse JM, Giltay EJ, Grobbee DE, Donders ART, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002; 20: 1493-1499. (Pubitemid 34921171)
26. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASHCollaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
27. Ohta Y, Tsuchihashi T, Arakawa K, Onaka U, Ueno M. Prevalence and lifestyle characteristics of hypertensive patients with metabolic syndrome followed at an outpatient clinic in Fukuoka, Japan. Hypertens Res 2007; 30: 1077-1082.
28. Kobayashi J, Nishimura K, Matoba M. Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome. Circ J 2007; 71: 1734-1737. (Pubitemid 350240094)
29. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357: 848-851. (Pubitemid 32239370)
30. Matsui H, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, Liu J, Ando K, Fujita T. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension 2006; 48: 225-231. (Pubitemid 44309816)